Elevance Health (ELV) Change in Accured Expenses (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Accured Expenses data on file, last reported at $2.9 billion in Q1 2026.

• Quarterly Change in Accured Expenses rose 203.15% year-over-year to $2.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 29.56% YoY) and the FY2025 annual result came in at -$720.0 million, down 164.71% from the prior year.
• Change in Accured Expenses climbed to $2.9 billion in Q1 2026 per ELV's latest filing, from -$2.3 billion in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.9 billion in Q1 2026 and bottomed at -$2.3 billion in Q4 2025.
• The 5-year median for Change in Accured Expenses is $204.0 million (2022), against an average of $256.4 million.
• The widest annual swing landed in 2023, when Change in Accured Expenses soared 4679.41%; it then plunged 1527.78% in 2024.
• Tracing ELV's Change in Accured Expenses over 5 years: stood at $226.0 million in 2022, then sank by 134.07% to -$77.0 million in 2023, then sank by 1458.44% to -$1.2 billion in 2024, then sank by 88.25% to -$2.3 billion in 2025, then surged by 227.76% to $2.9 billion in 2026.
• Per Business Quant, the three latest ELV Change in Accured Expenses figures stand at $2.9 billion (Q1 2026), -$2.3 billion (Q4 2025), and -$151.0 million (Q3 2025).

Peer Comparison